RIKER LAUREN sold PCRX
January 5, 2026 · Form 4 insider transaction
RIKER LAUREN sold 1,416 shares of Pacira BioSciences, Inc. at $24.24 per share, a transaction worth $34.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,416
Price
$24.24
Total value
$34.3K
InsiderRIKER LAUREN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after59,064
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.